International Helmholtz Drug Discovery Conference

The biannual international Helmholtz Drug Discovery Conferences are very well established in the field of Chemical Biology as stimulating platforms for scientists from academia, biotech and pharmaceutical industries. HDDC2025 has a focus on RNA as drug and drug target, Novel cardiovascular drugs, PROTACs, Artificial Intelligence in Drug Discovery, Chemoproteomics and much more, and invites scientists from academia and industry to discuss the challenges and chances of modern drug discovery. Besides keynote presentations by internationally renowned speakers, oral and poster presentations selected from abstracts will allow participants to discuss their findings with expert peers. We also plan a session  in which start-up companies can present their activities in drug research. The location in Berlin with its multiple academic institutions, small and large biotech and pharmaceutical companies ensures a vibrant environment for the conference.
 

How to get to the venue

https://www.mdc-berlin.de/about/contact/berlin-buch

Registration and Abstract Submission

Registration and Abstract submission will open on October 1st, 2024

Registration Fees

Scientists from Academia             150€
Scientists from Industry                200€
Students                                           75€

Registration deadline: April 1^st, 2025

Abstract deadline for oral and poster presentations: extended to March 10^th, 2025 

The registration fee includes coffee breaks, lunch buffet and dinner buffet. The costs for accommodation and travel to the venue are not included in the registration fee and must be arranged independently.

Confirmed Speaker

Davide Calebiro                University of Birmingham, UK

Matthew Disney               The Scripps Research Institute, Jupiter, FL, USA

Stefan Engelhardt            Technical University of Munich, Germany

Massimiliano Gaetani       Karolinska Institutet, Stockholm, Sweden

Anne-Claude Gingras       Lunenfeld-Tanenbaum Research Institute, Toronto, Canada

Ting Han                            Tsinghua University, Beijing, China

Michelle Hastings             University of Michigan Medical School, Ann Arbor, MI, USA

Carsten Hopf                    University Medical Centre Mannheim, Germany

Bernhard Küster               Technical University of Munich, Germany

Cristina Mayor-Ruiz          Institute for Research in Biomedicine, Barcelona, Spain

Grzegorz Popowicz          Helmholtz Munich, Germany

Brian Shoichet                   University of California San Francisco, USA

Simone Spuler                   Charité University Medicine Berlin, Germany

Edward Tate                      Imperial College London, UK

Thomas Thum                   Hannover Medical School, Germany

Juan Valcarcel                   Barcelona Institute of Science and Technology, Spain

Helma Wennemers            ETH Zürich, Switzerland

Sponsoring Options

Sponsorpackagesnew.pdf (PDF, 85.64 KB)

Contact

Scientfic Contact

 

Prof. Dr. Michael Bader
Max Delbrück Center for Molecular Medicine in the Helmholtz Association
Robert-Rössle-Str. 10
13125 Berlin
Phone: +49 30 94064255
E-Mail: mbader@mdc-berlin.de

 

Dr. Edgar Specker
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Robert-Rössle-Str. 10
13125 Berlin
Phone: +49 30 94793510
E-Mail: Specker@fmp-berlin.de

 

 

Conference Office

Matthias Runow
Congress Manager
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Robert-Rössle-Str. 10
13125 Berlin
Phone: +49 30 94063720

Dr. Timkehet Teffera
Congress Manager
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Robert-Rössle-Str. 10
13125 Berlin
Phone: +49 30 94064255

Lien-Georgina Dettmann
Congress Manager
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Robert-Rössle-Str. 10
13125 Berlin
Phone: +49 30 94062719

E-Mail: events@mdc-berlin.de